I have a peptide that I am immobilizing onto an SPR chip via His tag. I am concerned that if the His6 sequence is placed right next to the binding sequence, steric hindrances will prevent analyte interactions. However, a spacer sequence should prevent this from happening. Also, is there a substantial difference if the His tag is placed at the C or N terminus of the peptide?